Fractyl Health, Inc. Operating Cash Flow
Fractyl Health, Inc. (GUTS) reported Operating Cash Flow of -$38.38 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-10
- Fractyl Health, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$15.90M.
- Fractyl Health, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$22.48M.
- Fractyl Health, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$21.34M.
- Fractyl Health, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$22.71M.
- Fractyl Health, Inc. net cash provided by (used in) operating activities for fiscal 2025 was -$90.33M.
- Fractyl Health, Inc. net cash provided by (used in) operating activities for fiscal 2024 was -$65.52M.
- Fractyl Health, Inc. net cash provided by (used in) operating activities for fiscal 2023 was -$42.82M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$15.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$38.38M 10-Q · filed 2026-08-10 | -$59.71M derived: sum of 3 quarters · filed 2026-08-10 | -$82.43M derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | -$22.48M 10-Q · filed 2026-05-12 | -$43.81M derived: sum of 2 quarters · filed 2026-05-12 | -$66.53M derived: sum of 3 quarters · filed 2026-05-12 | -$87.73M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | -$21.34M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | -$44.05M derived: sum of 2 quarters · filed 2026-03-24 | -$65.25M derived: sum of 3 quarters · filed 2026-08-10 | -$90.33M 10-K · filed 2026-03-24 |
| 2025-09-30 | -$22.71M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$43.91M derived: sum of 2 quarters · filed 2026-08-10 | -$68.99M 10-Q · filed 2025-11-12 | -$86.03M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | -$21.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$46.28M 10-Q · filed 2026-08-10 | -$63.31M derived: sum of 3 quarters · filed 2026-08-10 | -$81.35M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | -$25.08M 10-Q · filed 2026-05-12 | -$42.11M derived: sum of 2 quarters · filed 2026-05-12 | -$60.15M derived: sum of 3 quarters · filed 2026-05-12 | -$78.89M derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | -$17.03M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | -$35.07M derived: sum of 2 quarters · filed 2026-03-24 | -$53.81M derived: sum of 3 quarters · filed 2026-03-24 | -$65.52M 10-K · filed 2026-03-24 |
| 2024-09-30 | -$18.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$36.78M derived: sum of 2 quarters · filed 2025-11-12 | -$48.49M 10-Q · filed 2025-11-12 | -$59.09M derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | -$18.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | -$30.45M 10-Q · filed 2025-08-12 | -$41.05M derived: sum of 3 quarters · filed 2025-08-12 | -$52.06M derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | -$11.71M 10-Q · filed 2025-05-13 | -$22.31M derived: sum of 2 quarters · filed 2025-05-13 | -$33.33M derived: sum of 3 quarters · filed 2025-05-13 | -$44.98M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | -$10.60M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | -$21.62M derived: sum of 2 quarters · filed 2025-03-03 | -$33.27M derived: sum of 3 quarters · filed 2025-03-03 | -$42.82M 10-K · filed 2025-03-03 |
| 2023-09-30 | -$11.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$22.67M derived: sum of 2 quarters · filed 2024-11-12 | -$32.22M 10-Q · filed 2024-11-12 | |
| 2023-06-30 | -$11.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$21.21M 10-Q · filed 2024-08-14 | ||
| 2023-03-31 | -$9.55M 10-Q · filed 2024-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |